-
Richard F. Heck Chemist Who Revolutionized Drug Development Dies at 84
The New York Times | Dr. Heck shared the 2010 Nobel Prize in Chemistry for creating techniques to synthesize complex carbon molecules that are now used to make drugs, electronics and other products.
Oct 16, 2015
-
The cloud changes IT culture demands new tech skills
Computerworld | Moving to the Cloud is changing more than just data location. It's changing everything about the skills IT workers need to do their jobs and what those jobs entail.
Oct 15, 2015
-
23andMe Caps a Year of Recovery with a $115 Million Funding Round
Forbes | With a drug discovery business, an FDA-cleared test, and a new valuation at over $1 billions, 23andMe is once again on the upswing, writes Matthew Herper.
Oct 14, 2015
-
The Social Face of Genetics at the American Society of Human Genetics Meeting
Bio-IT World | The annual meeting of the ASHG convened last week in Baltimore, in the midst of a new Precision Medicine Initiative that aims to collect one million patients' genomes and medical records into a national cohort. As NIH Director Francis Collins spoke about the possibilities and social responsibilities of that project, ASHG President Neil Risch reflected on past and ongoing misuses of genetics, and a panel of science journalists considered how scientists can best engage the public, build trust, and help non-professionals wrangle with the real-world implications of new discoveries.
Oct 14, 2015
-
Elizabeth Parrish CEO of BioViva Claims to Undergo Anti-Aging Therapy
MIT Technology Review | An American woman claims she is the first to undergo gene therapy to reverse aging. Judge for yourself.
Oct 14, 2015
-
New Products and Announcements at the American Society of Human Genetics Meeting
Bio-IT World | Companies including Illumina, Complete Genomics, Pacific Biosciences, Invitae, QIAGEN, and DNAnexus gathered this week at the annual meeting of the American Society of Human Genetics in Baltimore to show off their latest products and services.
Oct 9, 2015
-
Amazon wants companies to get onto its cloud using new services
Computerworld | Amazon launched a handful of new services all aimed at getting companies onto its cloud platform Wednesday, including a new ruggedized box for shipping data to the cloud provider.
Oct 9, 2015
-
Estonia Is Embracing Personalized Medicine With Its DNA Biobank
The Atlantic | The country's genetic biobank is still in its earliest stages, but the government hopes to one day have enough donors to totally overhaul its health-care system.
Oct 9, 2015
-
GENALICE Launches Population Calling Analysis Module
Bio-IT World In a live webinar today, GENALICE launched the Population Calling analysis module to their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. In partnership with Mount Sinai Hospital, Amazon Web Services, and Intel, GENALICE processed the whole genomes of 800 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an Alzheimer’s disease cohort during the webinar.
Oct 8, 2015
-
GSK Updates on Social Media Tracking
MobiHealthNews | GlaxoSmithKline and Epidemico won a 2015 Bio-IT World Best Practices award last year for ProjectCRAWL, an effort to survey social media to alert GSK to adverse events. Yesterday, GSK's director of pharmacovigilance gave an update on how the pharma is using Epidemico's data.
Oct 6, 2015
-
With Cleversafe buy IBM zeroes in on unstructured data
Computerworld | IBM will acquire object-based storage vendor Cleversafe in a move to bolster its cloud business unit with more flexibility and simplified management options in the hybrid cloud, it announced on Monday.
Oct 5, 2015
-
Can the New Google Have a Long and Productive Life?
MIT Technology Review | To truly change the world, Google's new holding company will need something that has eluded many previous industrial labs: an effective commercialization strategy.
Oct 2, 2015
-
A Worthy Sequel: PacBio's New Sequencing System
Bio-IT World | Pacific Biosciences has released a new genome sequencing instrument, the Sequel — providing the first-in-class whole genome assemblies of its predecessor the RS II, but much faster and at half the cost. But the company's underlying problems, pitching high quality in a price-sensitive market, are not much changed.
Oct 1, 2015


